Condition
Recurrent Endometrial Cancer clinical trials and research
Research outlook What's coming for Endometrial cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Recurrent Endometrial Cancer clinical trials that are recruiting, at sites in 10 countries (most in United States (4), Australia (1), Belgium (1)). By phase: Phase 2 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 10Countries
Newest Recurrent Endometrial Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| One year vs two years of maintenance immunotherapy for endometrial cancer | Phase 3 | Cary, North Carolina and 5 other locations | Recruiting | Oct 9, 2026 |
| Pembrolizumab and Lenvatinib for recurrent endometrial cancer that has progressed after first-line therapy | Phase 2 | Miami, Florida | Recruiting | May 18, 2026 |
| Comparing Letrozole/Abemaciclib to Pembrolizumab for Endometrial Cancer Maintenance | Phase 2 | Aurora, Colorado and 7 other locations | Recruiting | Apr 15, 2024 |
| Treatment for recurrent ovarian and other MUC16+ cancers using REGN4018 and cemiplimab | Phase 1/2 | Birmingham, Alabama and 53 other locations | Recruiting | Jun 20, 2018 |
All recruiting trials (4)
-
One year vs two years of maintenance immunotherapy for endometrial cancer
This trial tests whether keeping pembrolizumab or dostarlimab for one year works as well as two years for people with advanced, recurrent, or metastatic endometrial cancer who completed initial chemo and anti-PD1 therapy.
-
Pembrolizumab and Lenvatinib for recurrent endometrial cancer that has progressed after first-line therapy
This trial tests a combination of pembrolizumab and lenvatinib to see if it can help adults with recurrent mismatch repair-proficient endometrial cancer after failure of initial platinum-based chemo and immunotherapy.
-
Comparing Letrozole/Abemaciclib to Pembrolizumab for Endometrial Cancer Maintenance
This study is testing whether a combination of letrozole and abemaciclib can help people with advanced or recurring endometrial cancer feel better compared to taking pembrolizumab alone after their initial chemotherapy.
-
Treatment for recurrent ovarian and other MUC16+ cancers using REGN4018 and cemiplimab
This study is testing if a new treatment combining REGN4018 and cemiplimab can help adults with recurrent ovarian and other MUC16+ cancers feel better when other options have run out.
Related topics
Quick answers
How many Recurrent Endometrial Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), Australia (1 trial), Belgium (1 trial), France (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.